InvestorsHub Logo
Followers 0
Posts 283
Boards Moderated 0
Alias Born 09/26/2012

Re: None

Friday, 01/04/2013 9:26:31 PM

Friday, January 04, 2013 9:26:31 PM

Post# of 130746
Since EPGL Medical Science chooses a Singapore based firm, my friends in Japan found it extremely valuable and important wise move on EPGL's part (American Company), utilizing cost effective measures due to "friendlier business climate" in Singapore to distribute throughout the rest of Asia.

EPGL Med @EPGLMed
EPGL Selects a Singapore based firm for its Asia distribution. This, among other news will be detailed in January 25, 2013 announcements.



Just something to be aware of, and understand, this helps us shareholders greatly when the time comes for the gates to open on the MPDD and future MPTT's....

Though some Asian countries generally have smaller medical markets than those of Japan, China, India, and Korea, many of these other Asian countries oftentimes offer easier regulatory approval and market access than their larger Asian neighbors. Sometimes, distributors in these other countries can get your products on the market fairly quickly.


Do you want to play? Then get in..
Do you want to watch and wait? Do as you please....watch forever then, won't bother the rest of us.


Lets see whats in store for January 25, 2013
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.